Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119694) titled 'Clinical and immunological studies of isotretinoin for the treatment of acne vulgaris' on March 2.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: the First Hospital of China Medical University
Condition:
Acne vulgaris
Intervention:
Group of mild acne:Low-dose isotretinoin <0.5 mg/kg/day
Group of moderate acne:Low-dose isotretinoin <0.5 mg/kg/day
Group of severe acne:Low-dose isotretinoin <0.5 mg/kg/day
Group A:Target cumulative dose 60 mg/kg
Group B:Target cumulative dose 90 mg/kg
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-02
Target Sam...